ANASTASIOS GIANAKAKOS Insider Trading $MYOK MyoKardia, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANASTASIOS GIANAKAKOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANASTASIOS GIANAKAKOS. ANASTASIOS GIANAKAKOS is SVP, COR & Business Dev in MAP Pharmaceuticals, Inc. ($MAPP) and President and CEO in MyoKardia Inc ($MYOK).
ANASTASIOS GIANAKAKOS in MyoKardia, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANASTASIOS GIANAKAKOS: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 19 2020
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANASTASIOS GIANAKAKOS in MyoKardia, Inc.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.95 | 1,300 | 62,335 | 74,949 | 76.2 K to 74.9 K (-1.70 %) |
| May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.27 | 1,700 | 80,365 | 76,249 | 77.9 K to 76.2 K (-2.18 %) |
| May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 2,981 | 4,492 | 77,949 | 75 K to 77.9 K (+3.98 %) |
| May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 33.15 | 578 | 19,161 | 74,968 | 74.4 K to 75 K (+0.78 %) |
| Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 126,235 | |
| Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 48.44 | 1,225 | 59,338 | 74,390 | 75.6 K to 74.4 K (-1.62 %) |
| Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.62 | 1,775 | 84,526 | 75,615 | 77.4 K to 75.6 K (-2.29 %) |
| Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,390 | 74.4 K to 77.4 K (+4.03 %) |
| Mar 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 129,235 | |
| Mar 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 61.07 | 3,000 | 183,205 | 74,390 | 77.4 K to 74.4 K (-3.88 %) |
| Mar 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,390 | 74.4 K to 77.4 K (+4.03 %) |
| Feb 28 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 5,000 | 7,534 | 132,235 | |
| Feb 28 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 60.00 | 5,000 | 300,000 | 74,390 | 79.4 K to 74.4 K (-6.30 %) |
| Feb 28 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 5,000 | 7,534 | 79,390 | 74.4 K to 79.4 K (+6.72 %) |
| Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 137,235 | |
| Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 52.58 | 200 | 10,515 | 74,390 | 74.6 K to 74.4 K (-0.27 %) |
| Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 51.92 | 1,147 | 59,547 | 74,590 | 75.7 K to 74.6 K (-1.51 %) |
| Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.91 | 699 | 35,587 | 75,737 | 76.4 K to 75.7 K (-0.91 %) |
| Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 49.78 | 954 | 47,491 | 76,436 | 77.4 K to 76.4 K (-1.23 %) |
| Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,390 | 74.4 K to 77.4 K (+4.03 %) |
| Jan 18 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 0.00 | 30,600 | 0 | 30,600 | |
| Jan 18 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 52.00 | 184,100 | 9,573,200 | 184,100 | |
| Jan 16 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 5,000 | 7,534 | 146,912 | |
| Jan 16 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.00 | 5,000 | 250,000 | 509,117 | 514.1 K to 509.1 K (-0.97 %) |
| Jan 16 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 5,000 | 7,534 | 514,117 | 509.1 K to 514.1 K (+0.98 %) |
| Jan 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 151,912 | |
| Jan 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 41.70 | 3,000 | 125,103 | 509,117 | 512.1 K to 509.1 K (-0.59 %) |
| Jan 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 512,117 | 509.1 K to 512.1 K (+0.59 %) |
| Dec 26 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 154,912 | |
| Dec 26 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 41.09 | 3,000 | 123,268 | 509,117 | 512.1 K to 509.1 K (-0.59 %) |
| Dec 26 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 512,117 | 509.1 K to 512.1 K (+0.59 %) |
| Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 157,912 | |
| Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 40.18 | 1,100 | 44,200 | 509,117 | 510.2 K to 509.1 K (-0.22 %) |
| Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 40.25 | 3,200 | 128,790 | 510,217 | 513.4 K to 510.2 K (-0.62 %) |
| Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 513,417 | 509.1 K to 513.4 K (+0.84 %) |
| Nov 03 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 11.56 | 954 | 11,028 | 509,117 | 508.2 K to 509.1 K (+0.19 %) |
| Oct 06 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 162,212 | |
| Oct 06 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 40.86 | 4,300 | 175,699 | 508,163 | 512.5 K to 508.2 K (-0.84 %) |
| Oct 06 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 512,463 | 508.2 K to 512.5 K (+0.85 %) |
| Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 166,512 | |
| Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 43.67 | 300 | 13,102 | 508,163 | 508.5 K to 508.2 K (-0.06 %) |
| Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 42.98 | 4,000 | 171,902 | 508,463 | 512.5 K to 508.5 K (-0.78 %) |
| Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 512,463 | 508.2 K to 512.5 K (+0.85 %) |
| Aug 04 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 170,812 | |
| Aug 04 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 16.62 | 4,300 | 71,465 | 508,163 | 512.5 K to 508.2 K (-0.84 %) |
| Aug 04 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 512,463 | 508.2 K to 512.5 K (+0.85 %) |
| Jul 27 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 31,850 | 48,094 | 175,112 | |
| Jul 27 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 15.00 | 32,988 | 494,902 | 508,163 | 541.2 K to 508.2 K (-6.10 %) |
| Jul 27 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 31,850 | 48,094 | 541,151 | 509.3 K to 541.2 K (+6.25 %) |
| May 16 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 11.09 | 1,259 | 13,965 | 509,301 | 508 K to 509.3 K (+0.25 %) |
| Mar 27 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 1.51 | 27,891 | 42,115 | 55,782 | |
| Mar 22 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 1,200 | 1,812 | 206,962 | |
| Mar 22 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 15.00 | 1,412 | 21,180 | 508,042 | 509.5 K to 508 K (-0.28 %) |
| Mar 22 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 1,200 | 1,812 | 509,454 | 508.3 K to 509.5 K (+0.24 %) |
| Jan 20 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 12.25 | 303,500 | 3,717,875 | 303,500 | |
| Nov 02 2016 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 1.51 | 27,891 | 42,115 | 27,891 | |
| Nov 02 2016 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 10.03 | 898 | 9,007 | 508,254 | 507.4 K to 508.3 K (+0.18 %) |
| May 06 2016 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | P | 8.50 | 2,279 | 19,372 | 484,444 | 482.2 K to 484.4 K (+0.47 %) |
| Feb 04 2016 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 9.08 | 72,562 | 658,863 | 72,562 | |
| Nov 05 2015 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | P | 10.00 | 1,350 | 13,500 | 482,165 | 480.8 K to 482.2 K (+0.28 %) |